Alternative za pretragu:
harm » arm (Proširi pretragu), farm (Proširi pretragu), hard (Proširi pretragu)
resolve. » resolved. (Proširi pretragu)
harm » arm (Proširi pretragu), farm (Proširi pretragu), hard (Proširi pretragu)
resolve. » resolved. (Proširi pretragu)
-
81
-
82
-
83
-
84
-
85
-
86
-
87
Trends in the valuation of injury involving the face: an analysis on trial in Rio Grande do Sul, Brazil
Izdano 2020“…To measure the damage, the assessment of the bodily harm is required. Objective To analyze jurisprudential characteristics involving the valuation of the damage related to facial trauma, highlighting trends Methods It was analyzed secondary data, which are public domain, of the precedents of the Court of Justice of Rio Grande do Sul State from 2008 to 2016. …”
-
88
-
89
-
90
Table_3_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx
Izdano 2020“…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
-
91
Table_1_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx
Izdano 2020“…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
-
92
Table_2_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx
Izdano 2020“…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
-
93
-
94
-
95
-
96
-
97
Patient Involvement in Preparing Clinical Research Peer-Reviewed Publications or Results Summaries: A Systematic Review
Izdano 2018“…<div><b>Objective</b></div><div>Although patient involvement in results reporting is being encouraged, relevant evidence must be assessed before developing best practice guidelines. …”
-
98
-
99
-
100